Kylie Swenson, OHSU clinical trial patient
Credit: OHSU News
Kylie Swenson, 39, is an OHSU clinical trial participant who lives in Central Point. The clinical trial uses a form of chimeric antigen receptor, or CAR-T, to treat generalized myasthenia gravis, or MG, a debilitating autoimmune neurological disease. (Courtesy of Kylie Swenson)